NASDAQ:SPRB

Spruce Biosciences Stock Forecast

etoro logo Buy SPRB
*Your capital is at risk
$48.38
-1.69 (-3.38%)
At Close: Jul 13, 2026
AI Analysis AI Analysis of SPRB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add SPRB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Monday for Spruce Biosciences, Inc.
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 10, 2026 Loss -3.38%

The Spruce Biosciences, Inc. stock price fell by -3.38% on the last day (Monday, 13th Jul 2026) from $50.07 to $48.38. During the last trading day the stock fluctuated 9.73% from a day low at $48.16 to a day high of $52.85. The price has fallen in 8 of the last 10 days and is down by -12.21% for this period. Volume has increased on the last day by 47 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 103 thousand shares were bought and sold for approximately $5.00 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.78% during the next 3 months and, with a 90% probability hold a price between $36.44 and $49.09 at the end of this 3-month period.

SPRB Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 2.72%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Spruce Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $50.73 and $51.06. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Spruce Biosciences, Inc. stock

Spruce Biosciences, Inc. finds support from accumulated volume at $48.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.69 between high and low, or 9.73%. For the last week, the stock has had daily average volatility of 6.09%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SPRB) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Spruce Biosciences, Inc. to open at $49.80, and during the day (based on 14 day Average True Range), to move between $46.70 and $50.06, which gives a possible trading interval of +/-$3.37 (+/-7.21%) up or down from last closing price. If Spruce Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 7.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $48.25 (0.27%) than the resistance at $51.69 (6.84%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Spruce Biosciences, Inc. stock A Buy?

Spruce Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.109 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $49.80 ( 2.92%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

SPRB Performance

Trading levels for SPRB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 54.48 12.61%
R2 52.69 8.91%
R1 51.58 6.62%
Price 48.38
S1 48.01 -0.774%
S2 46.90 -3.06%
S3 45.11 -6.76%

Accumulated Volume Support & Resistance Levels

Level Price
R3 55.11 13.91%
R2 52.36 8.23%
R1 51.69 6.84%
Price 48.38
S1 48.25 -0.269%
S2 47.13 -2.58%
S3 47.10 -2.65%

FAQ

What is the symbol for Spruce Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Spruce Biosciences, Inc. is SPRB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Spruce Biosciences, Inc. Stock?
Spruce Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Spruce Biosciences, Inc. Stock?
Spruce Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Spruce Biosciences, Inc. Stock.

What's the current price of Spruce Biosciences, Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an Spruce Biosciences, Inc. (SPRB) share was $48.38.

What is the 52-week high and low for Spruce Biosciences, Inc. Stock?
The 52-week high for Spruce Biosciences, Inc. Stock is $240.00 and the 52-week low is $0.0829.

What is the market capitalization of Spruce Biosciences, Inc. Stock?
As of the Jul 13, 2026, the market capitalization of Spruce Biosciences, Inc. is 66.379M.

When is the next earnings date for Spruce Biosciences, Inc.?
The upcoming earnings date for Spruce Biosciences, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT SPRUCE BIOSCIENCES, INC.
Spruce Biosciences
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adu...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE